Corrigendum to “Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)”: [ESMO Open 7 (2024) 100552] (ESMO Open (2022) 7(4), (S2059702922001806), (10.1016/j.esmoop.2022.100552))

German Pancreatic Cancer Group (AIO-PAK) and NEOLAP investigators

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Corrigendum to “Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)”: [ESMO Open 7 (2024) 100552] (ESMO Open (2022) 7(4), (S2059702922001806), (10.1016/j.esmoop.2022.100552))'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Veterinary Science and Veterinary Medicine